Donepezil overdose secondary to use of a smart home device for medication reminders.

Br J Hosp Med (Lond)

Department of Cardiology, Salisbury District Hospital, Salisbury, UK.

Published: January 2022

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2021.0243DOI Listing

Publication Analysis

Top Keywords

donepezil overdose
4
overdose secondary
4
secondary smart
4
smart device
4
device medication
4
medication reminders
4
donepezil
1
secondary
1
smart
1
device
1

Similar Publications

Treating Diphenhydramine Overdose: A Literature Review of Currently Available Treatment Methods.

Toxics

May 2024

College of Graduate Studies, Midwestern University, 555 31st Street, Downers Grove, IL 60515, USA.

Article Synopsis
  • From 2019 to 2020, antihistamines were involved in 15% of US drug overdose deaths, with diphenhydramine being the most common, and 3.6% of those deaths attributed solely to antihistamines.
  • There is currently no specific antidote for diphenhydramine overdose, highlighting a gap in emergency treatment options.
  • The review evaluates various treatments for antihistamine overdose, including traditional and newer methods, concluding that further research is necessary to identify the best therapeutic strategies.
View Article and Find Full Text PDF

Distribution of donepezil in postmortem casework.

J Forensic Leg Med

January 2024

NMS Labs, 200 Welsh Rd, Horsham, PA, USA.

Donepezil is one of the primary treatments options for patients suffering from Alzheimer's Disease. In a review of more than 2200 postmortem donepezil positive blood specimens, 76% of concentrations were higher than the proposed therapeutic range. Means and medians were similar between central blood specimens and peripheral specimens, indicating minimal postmortem redistribution.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!